# ZNF689

## Overview
ZNF689 is a gene that encodes the zinc finger protein 689, a member of the KRAB-zinc finger family of transcriptional repressors. This protein is primarily involved in transcriptional regulation and apoptosis modulation within human cells. Zinc finger protein 689 functions by interacting with various nuclear proteins, including TIF1β and nucleolin, to repress the transcription of pro-apoptotic genes such as Bak and Bax, thereby inhibiting apoptosis through a caspase-dependent pathway (Shigematsu2011ZNF689). The protein's activity is mediated through its KRAB domain, which recruits histone deacetylase complexes, further contributing to its role as a transcriptional repressor (Shigematsu2011ZNF689). ZNF689 is also implicated in cancer biology, particularly in hepatocellular carcinoma, where it is upregulated and associated with tumor progression and chemotherapy resistance (Shigematsu2011ZNF689). Its expression levels and interactions suggest potential as a therapeutic target in various cancer types, including triple-negative breast cancer and kidney renal clear cell carcinoma, where its role appears to be context-dependent (Czerwinska2021Low; Ge2024ZNF689).

## Function
ZNF689 is a zinc finger protein that functions primarily as a transcriptional repressor in human cells. It is involved in regulating apoptosis by modulating the expression of pro-apoptotic factors within the Bcl-2 family, such as Bak and Bax. ZNF689 achieves this by suppressing the promoter activity of these genes, thereby inhibiting apoptosis through a caspase-dependent pathway (Shigematsu2011ZNF689). 

The protein is localized in the nucleus, where it interacts with other proteins involved in transcription repression and RNA processing, including TIF1β, hnRNPU, hnRNPF, and nucleolin. This interaction suggests a role in transcriptional regulation and possibly ribosome biogenesis (Shigematsu2011ZNF689). ZNF689's activity is mediated through its KRAB domain, which recruits the histone deacetylase complex, contributing to its function as a transcriptional repressor (Shigematsu2011ZNF689).

ZNF689 is also implicated in cancer biology, particularly in hepatocellular carcinoma, where it is upregulated and contributes to tumor progression by inhibiting apoptotic signaling pathways (Shigematsu2011ZNF689). Its expression is associated with resistance to chemotherapy, highlighting its potential as a therapeutic target (Shigematsu2011ZNF689).

## Clinical Significance
ZNF689 is implicated in several cancers, notably hepatocellular carcinoma (HCC) and triple-negative breast cancer (TNBC). In HCC, ZNF689 is upregulated and functions as an anti-apoptotic factor by down-regulating pro-apoptotic Bcl-2 family members such as Bak and Bax. This suppression of apoptosis contributes to tumor progression and resistance to chemotherapeutic drugs like 5-fluorouracil (5-FU) (Shigematsu2011ZNF689). Knockdown of ZNF689 in HCC cells induces apoptosis through a caspase-dependent pathway, suggesting its potential as a therapeutic target (Shigematsu2011ZNF689). ZNF689 is also identified as a target of microRNA-339, which is downregulated in HCC. Overexpression of miR-339 suppresses ZNF689, inhibiting HCC proliferation and invasion, indicating a negative correlation between miR-339 and ZNF689 expression (Zeng2019&lt; p&gt; MicroRNA339).

In TNBC, ZNF689 deficiency is associated with increased intratumor heterogeneity and resistance to immunotherapy, highlighting its role in maintaining genomic stability and affecting tumor response to treatment (Ge2024ZNF689). In kidney renal clear cell carcinoma (KIRC), high ZNF689 expression correlates with better survival outcomes, suggesting its role in cancer is context-dependent (Czerwinska2021Low).

## Interactions
ZNF689 is known to interact with several proteins, playing a role in transcriptional repression and apoptosis regulation. It interacts with TIF1β, a transcriptional corepressor that recruits the histone deacetylase (HDAC) complex to DNA, suggesting that ZNF689 may regulate transcription repression and RNA processing of genes essential for cell growth control (Shigematsu2011ZNF689). ZNF689 also interacts with hnRNPU, hnRNPF, and nucleolin, a protein essential for pre-ribosome assembly, indicating a potential role in ribosome biogenesis (Itokawa2009KAP1independent; Shigematsu2011ZNF689).

The protein is a member of the KRAB-zinc finger family of transcriptional repressors and negatively regulates pro-apoptotic Bcl-2 family members such as Bak and Bax. Knockdown of ZNF689 leads to increased expression of these pro-apoptotic genes, suggesting that ZNF689 suppresses apoptosis by repressing their transcription (Shigematsu2011ZNF689). ZNF689's interaction with nucleolin and its presence in the nucleolus further support its involvement in cellular processes related to ribosome biogenesis and transcriptional regulation (Shigematsu2011ZNF689). These interactions highlight ZNF689's role in modulating apoptotic signaling and transcriptional repression in cancer cells.


## References


[1. (Itokawa2009KAP1independent) Yasuhide Itokawa, Toshihide Yanagawa, Hisashi Yamakawa, Naoko Watanabe, Hisashi Koga, and Takahiro Nagase. Kap1-independent transcriptional repression of scan-krab-containing zinc finger proteins. Biochemical and Biophysical Research Communications, 388(4):689–694, October 2009. URL: http://dx.doi.org/10.1016/j.bbrc.2009.08.065, doi:10.1016/j.bbrc.2009.08.065. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2009.08.065)

[2. (Ge2024ZNF689) Li-Ping Ge, Xi Jin, Ding Ma, Zi-Yu Wang, Cheng-Lin Liu, Chao-Zheng Zhou, Shen Zhao, Tian-Jian Yu, Xi-Yu Liu, Gen-Hong Di, Zhi-Ming Shao, and Yi-Zhou Jiang. Znf689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer. Cell Research, 34(1):58–75, January 2024. URL: http://dx.doi.org/10.1038/s41422-023-00909-w, doi:10.1038/s41422-023-00909-w. This article has 5 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41422-023-00909-w)

[3. (Czerwinska2021Low) Patrycja Czerwinska and Andrzej Adam Mackiewicz. Low levels of trim28-interacting krab-znf genes associate with cancer stemness and predict poor prognosis of kidney renal clear cell carcinoma patients. Cancers, 13(19):4835, September 2021. URL: http://dx.doi.org/10.3390/cancers13194835, doi:10.3390/cancers13194835. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers13194835)

[4. (Shigematsu2011ZNF689) Shuichiro Shigematsu, Shinji Fukuda, Hironao Nakayama, Hirofumi Inoue, Yoichi Hiasa, Morikazu Onji, and Shigeki Higashiyama. Znf689 suppresses apoptosis of hepatocellular carcinoma cells through the down-regulation of bcl-2 family members. Experimental Cell Research, 317(13):1851–1859, August 2011. URL: http://dx.doi.org/10.1016/j.yexcr.2011.05.012, doi:10.1016/j.yexcr.2011.05.012. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2011.05.012)